Chongqing Zhifei Biological Products Co., Ltd.
300122
Rangering i aksjer
#3688
Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily... Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily engaged in the innovation, manufacturing, and commercialization of vaccines and other biological pharmaceuticals within the country. The company's establishment dates back to 2009, and its main operational base is located in Chongqing, China.
Aksjekurs
$1.91
Markedsverdi
$4.57B
Endring (1 dag)
5.32%
Endring (1 år)
-32.90%
Land
CN
Handel Chongqing Zhifei Biological Products Co., Ltd. (300122)
Kategori
Healthcare
P/S-forhold for Chongqing Zhifei Biological Products Co., Ltd. (300122)
P/S-forhold per October 2026 TTM: 3.75
Ifølge Chongqing Zhifei Biological Products Co., Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 3.75. Ved slutten av 2023 hadde selskapet et P/S-forhold på 2.71.
P/S-historikk for Chongqing Zhifei Biological Products Co., Ltd. fra 2007 til 2026
P/S-forhold ved hvert års slutt
| År | P/S-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 3.75 | 54.82% |
| 2024 | 2.42 | -10.83% |
| 2023 | 2.71 | -26.21% |
| 2022 | 3.67 | -15.30% |
| 2021 | 4.34 | -58.25% |
| 2020 | 10.39 | 107.58% |
| 2019 | 5.00 | -32.02% |
| 2018 | 7.36 | -67.72% |
| 2017 | 22.80 | -40.40% |
| 2016 | 38.25 | 41.02% |
| 2015 | 27.13 | 102.50% |
| 2014 | 13.40 | -18.92% |
| 2013 | 16.52 | 42.05% |
| 2012 | 11.63 | 2.40% |
| 2011 | 11.36 | 1.27% |
| 2010 | 11.22 | -52.73% |
| 2009 | 23.73 | -1.38% |
| 2008 | 24.06 | -17.35% |
| 2007 | 29.11 | 0.00% |
P/S-forhold for lignende selskaper eller konkurrenter
| Selskap | P/S-forhold | Forskjell i P/S-forhold | Land |
|---|---|---|---|
| 10.02 | 167.49% |
US
|
|
| 40.55 | 982.31% |
US
|
|
| 3.96 | 5.72% |
AU
|
|
| 10.15 | 170.81% |
NL
|
|
| - | - |
CH
|
